{
  "paperSlug": "ejdrup-2026-dopamine",
  "version": 3,
  "synthesizerPrompt": "You are reconstructing the argument of a scientific paper from its decomposed claim structure.\n\nYou have only the claims and the relations between them. You do not have the paper's title, abstract, prose, authors, or interpretive framing. You see the claim sentences, the panels they're tied to, their argumentative role, and the structural relations between them.\n\nThe claim graph carries multiple kinds of relation, each representing a different argumentative move:\n\n- **`requires`** — A depends on B being true. Mechanistic / hierarchical chain.\n- **`entails` / `derived-from`** — Hypothesis → prediction. Deductive entailment.\n- **`tests`** — Empirical claim → prediction it tests.\n- **`supports` / `refutes`** — Empirical claim → hypothesis it supports or refutes. Abductive inference.\n- **`rules-out`** — A's evidence eliminates an alternative. Argument by elimination.\n- **`dissociates-with`** — A and B jointly establish a dissociation. Argument by contrast.\n- **`validates`** — A is a control or sign-flip that strengthens B. Argument by disconfirmation.\n- **`predicts` / `confirms`** — predictive validation across model and experiment.\n- **`scopes`** — A is a boundary condition on B (or on all claims). Argument by qualified scope.\n- **`interprets`** — A reframes empirical B through theoretical / literature lens. Argument by reframing — not derivation, but an act of mapping.\n- **`enables-method`** — A is the methodological capability that warrants B's interpretability.\n\nEach claim has a role: `hypothesis`, `prediction`, `empirical`, `synthesis`, `interpretation`, `methodological`, `control`, or `scope`.\n\nScientific argument typically combines three reasoning forms:\n- **Deduction** — `entails`/`derived-from` edges.\n- **Induction** — `requires`/`supports` edges.\n- **Abduction** — `supports`/`refutes` from empirical back to hypothesis.\n\nYour task: write a paragraph (200–400 words) articulating what this paper is arguing, derived from the structure alone, in the style of a scientific abstract.\n\nUse the right rhetorical move for the right structural relation. Honor epistemic markers and roles. Don't add background framing or literature you don't have. Don't speculate beyond claims. The structure of the argument should be visible in the prose.\n\nOutput:\n1. Synthesis paragraph\n2. Traceback\n\nClaim graph follows.\n\n---\n\n# Ejdrup et al. — Claim Graph (reconstructed)\n\n_Total claims: 23_\n\n\n## Hypotheses\n\n\n### Hypothesis: `hypothesis-d1-d2-temporal-distinction` (panel hypothesis; epistemic hypothesis; status unknown)\n    > D1 and D2 receptors operate on distinct temporal scales — D1 tracks burst DA with millisecond delay; D2 integrates over seconds and cannot resolve brief pauses.\n\n  - **entails (predictions/observations)**:\n    - `d1r-tracks-da-50ms-delay` (panel fig1H, fig1I; epistemic moderate; status verified)\n    > D1R occupancy closely tracks extracellular DA with approximately 50 ms delay during burst firing; D1R occupancy is negligible during pacemaker activity because the EC50 of 1000 nM far exceeds tonic [DA] of ~10 nM in DS, making burst events the effective threshold for D1R engagement.\n    - `d2r-integrates-over-seconds` (panel fig1H; epistemic weak; status verified)\n    > D2R occupancy takes at least 5 s to return to baseline after a burst due to slow off-kinetics (k_off = 0.2 s⁻¹), making D2R incapable of temporally separating closely linked bursts; the directional conclusion is robust but absolute occupancy values are sensitive to the initialization assumption.\n    - `d2r-insensitive-to-brief-pauses` (panel fig1J; epistemic weak; status verified)\n    > A complete 1 s pause in firing reduces D2R occupancy from approximately 0.55 to 0.45 only; this finding is robust across an order of magnitude of D2R affinity (2–20 nM).\n  - **tested by**:\n    - `d1r-tracks-da-50ms-delay` (panel fig1H, fig1I; epistemic moderate; status verified)\n    > D1R occupancy closely tracks extracellular DA with approximately 50 ms delay during burst firing; D1R occupancy is negligible during pacemaker activity because the EC50 of 1000 nM far exceeds tonic [DA] of ~10 nM in DS, making burst events the effective threshold for D1R engagement.\n    - `d2r-insensitive-to-brief-pauses` (panel fig1J; epistemic weak; status verified)\n    > A complete 1 s pause in firing reduces D2R occupancy from approximately 0.55 to 0.45 only; this finding is robust across an order of magnitude of D2R affinity (2–20 nM).\n    - `d2r-integrates-over-seconds` (panel fig1H; epistemic weak; status verified)\n    > D2R occupancy takes at least 5 s to return to baseline after a burst due to slow off-kinetics (k_off = 0.2 s⁻¹), making D2R incapable of temporally separating closely linked bursts; the directional conclusion is robust but absolute occupancy values are sensitive to the initialization assumption.\n\n### Hypothesis: `hypothesis-nanoclustering-regulates-vmax` (panel hypothesis; epistemic hypothesis; status unknown)\n    > DAT nanoclustering is a possible regulator of effective transporter activity, with denser clusters lowering effective Vmax via diffusion-limited substrate access — proposed as one contributor to the regional Vmax difference.\n\n  - **entails (predictions/observations)**:\n    - `dat-nanoclustering-slows-clearance` (panel fig4C, fig4D, fig4E, fig4F, fig4G; epistemic moderate; status partial:zenodo-data-downloaded)\n    > Dense DAT nanoclusters (20 nm diameter) take approximately 400 ms to clear a 100 nM DA bolus compared to approximately 200 ms for unclustered DAT, because local [DA] at the cluster surface drops near zero creating a diffusion-limited bottleneck.\n    - `dat-clustering-greater-in-vs` (panel fig4M, fig4N; epistemic moderate; status failed:mismatch)\n    > Super-resolution dSTORM imaging shows DAT is significantly more nanoclustered in VS than DS (p=0.012, Welch's two-sample t-test, n=12 DS, n=13 VS), consistent across cluster sizes 20–200 nm.\n  - **tested by**:\n    - `dat-clustering-greater-in-vs` (panel fig4M, fig4N; epistemic moderate; status failed:mismatch)\n    > Super-resolution dSTORM imaging shows DAT is significantly more nanoclustered in VS than DS (p=0.012, Welch's two-sample t-test, n=12 DS, n=13 VS), consistent across cluster sizes 20–200 nm.\n    - `dat-nanoclustering-slows-clearance` (panel fig4C, fig4D, fig4E, fig4F, fig4G; epistemic moderate; status partial:zenodo-data-downloaded)\n    > Dense DAT nanoclusters (20 nm diameter) take approximately 400 ms to clear a 100 nM DA bolus compared to approximately 200 ms for unclustered DAT, because local [DA] at the cluster surface drops near zero creating a diffusion-limited bottleneck.\n  - **scoped by (boundary conditions)**:\n    - `nanoclustering-constant-vmax-constraint` (panel fig4C, fig4D, fig4E, fig4F; epistemic moderate; status verified)\n    > The nanoclustering simulations hold total DAT Vmax constant across clustered and unclustered conditions — the per-voxel rate is multiplied by a normalization factor so total integrated uptake capacity is identical; if DAT nanoclustering co-occurs with increased total DAT expression in biology, the clearance-slowing result would not hold.\n    - `nanoclustering-model-varicosity-scale` (panel fig4C, fig4D, fig4E, fig4F; epistemic moderate; status verified)\n    > The nanoclustering simulations (Figure 4C–F) operate in a standalone varicosity-scale model (1.8 × 1.8 µm domain, 0.02 µm voxels) architecturally separate from the tissue-level model used in Figures 1–3 (100 µm domain, 1 µm voxels); no formal coupling exists between the two models and no effective-Vmax output from the nanoclustering simulation feeds into the tissue simulation.\n\n### Hypothesis: `hypothesis-vmax-explains-regional-difference` (panel hypothesis; epistemic hypothesis; status unknown)\n    > Regional differences in striatal DA dynamics (DS hotspots vs VS pervasive tonic coverage) are driven principally by DAT Vmax differences, not by release-side parameters.\n\n  - **entails (predictions/observations)**:\n    - `ds-lacks-pervasive-tonic-da` (panel fig1D, fig1E, fig1F; epistemic moderate; status verified)\n    > During 4 Hz pacemaker activity, the dorsal striatum produces partially segregated DA hotspots with large fractions of the simulated volume devoid of DA — there is no pervasive tonic baseline.\n    - `vs-maintains-pervasive-tonic-da` (panel fig2A, fig2B, fig2C; epistemic moderate; status verified)\n    > With DAT Vmax reduced to 33% of DS and terminal density at 90%, VS produces a diffuse tonic-like DA level throughout the simulated volume rather than segregated hotspots during 4 Hz pacemaker activity.\n    - `vmax-only-parameter-driving-regional-difference` (panel fig3B, fig3C, fig3E, fig3F, fig3G, fig3K, fig3L; epistemic strong; status verified)\n    > Across parameter sweeps of active terminal fraction, quantal size, release probability, and firing rate, only DAT Vmax generates differential responses between DS and VS; all other parameters shift both regions proportionally without altering the regional contrast.\n    - `vmax-modulation-larger-impact-in-vs` (panel fig3K; epistemic moderate; status verified)\n    > A ±50% change in DAT Vmax shifts tonic DA by 38 nM in VS but only 11 nM in DS, indicating VS operates closer to the Km saturation regime and is more sensitive to DAT modulation.\n    - `vs-low-active-fraction-resembles-ds-distribution` (panel fig3B; epistemic moderate; status unverified:compute-infeasible)\n    > VS at 5% active terminals produces a spatial DA distribution resembling DS at 100% active terminals, demonstrating VS operates in a low-focality high-coverage regime while DS requires dense terminal participation for equivalent spatial reach.\n    - `fscv-matches-may-wightman-1989` (panel fig2E; epistemic moderate; status unverified:compute-infeasible)\n    > Simulated FSCV responses to 10, 30, and 60 Hz stimulation closely replicate May & Wightman (1989): VS reaches considerably higher peak DA than DS at all three stimulation frequencies.\n  - **tested by**:\n    - `ds-lacks-pervasive-tonic-da` (panel fig1D, fig1E, fig1F; epistemic moderate; status verified)\n    > During 4 Hz pacemaker activity, the dorsal striatum produces partially segregated DA hotspots with large fractions of the simulated volume devoid of DA — there is no pervasive tonic baseline.\n    - `fscv-matches-may-wightman-1989` (panel fig2E; epistemic moderate; status unverified:compute-infeasible)\n    > Simulated FSCV responses to 10, 30, and 60 Hz stimulation closely replicate May & Wightman (1989): VS reaches considerably higher peak DA than DS at all three stimulation frequencies.\n    - `vmax-modulation-larger-impact-in-vs` (panel fig3K; epistemic moderate; status verified)\n    > A ±50% change in DAT Vmax shifts tonic DA by 38 nM in VS but only 11 nM in DS, indicating VS operates closer to the Km saturation regime and is more sensitive to DAT modulation.\n    - `vmax-only-parameter-driving-regional-difference` (panel fig3B, fig3C, fig3E, fig3F, fig3G, fig3K, fig3L; epistemic strong; status verified)\n    > Across parameter sweeps of active terminal fraction, quantal size, release probability, and firing rate, only DAT Vmax generates differential responses between DS and VS; all other parameters shift both regions proportionally without altering the regional contrast.\n    - `vs-low-active-fraction-resembles-ds-distribution` (panel fig3B; epistemic moderate; status unverified:compute-infeasible)\n    > VS at 5% active terminals produces a spatial DA distribution resembling DS at 100% active terminals, demonstrating VS operates in a low-focality high-coverage regime while DS requires dense terminal participation for equivalent spatial reach.\n    - `vs-maintains-pervasive-tonic-da` (panel fig2A, fig2B, fig2C; epistemic moderate; status verified)\n    > With DAT Vmax reduced to 33% of DS and terminal density at 90%, VS produces a diffuse tonic-like DA level throughout the simulated volume rather than segregated hotspots during 4 Hz pacemaker activity.\n  - **abductively supported by (additional)**:\n    - `dat-immunostaining-dorsoventral-gradient` (panel fig2—supplement 1B, fig2—supplement 1C; epistemic moderate; status unverified:no-data)\n    > DAT expression is significantly higher in dorsal than ventral striatum (p=0.0021, one-sided t-test, n=4 mice), corroborating the 3:1 Vmax ratio assumed in the model.\n    - `vmat2-gradient-absent` (panel fig2—supplement 1A, fig2—supplement 1B, fig2—supplement 1C; epistemic moderate; status unverified:no-data)\n    > VMAT2 immunostaining shows no significant dorsoventral gradient in striatum (p=0.0086, one-sided t-test, n=4 mice), ruling out differential release capacity as the primary explanation for regional DA differences.\n  - **validated by (control/sign-flip)**:\n    - `dat-immunostaining-dorsoventral-gradient` (panel fig2—supplement 1B, fig2—supplement 1C; epistemic moderate; status unverified:no-data)\n    > DAT expression is significantly higher in dorsal than ventral striatum (p=0.0021, one-sided t-test, n=4 mice), corroborating the 3:1 Vmax ratio assumed in the model.\n    - `vmat2-gradient-absent` (panel fig2—supplement 1A, fig2—supplement 1B, fig2—supplement 1C; epistemic moderate; status unverified:no-data)\n    > VMAT2 immunostaining shows no significant dorsoventral gradient in striatum (p=0.0086, one-sided t-test, n=4 mice), ruling out differential release capacity as the primary explanation for regional DA differences.\n\n## Eliminations / Controls\n\n\n### Control: `vmat2-gradient-absent` (panel fig2—supplement 1A, fig2—supplement 1B, fig2—supplement 1C; epistemic moderate; status unverified:no-data)\n    > VMAT2 immunostaining shows no significant dorsoventral gradient in striatum (p=0.0086, one-sided t-test, n=4 mice), ruling out differential release capacity as the primary explanation for regional DA differences.\n\n  - **rules-out**:\n    - differential VMAT2 expression / vesicular release capacity as the explanation for the DS/VS DA difference\n  - **supports**:\n    - `hypothesis-vmax-explains-regional-difference` (panel hypothesis; epistemic hypothesis; status unknown)\n    > Regional differences in striatal DA dynamics (DS hotspots vs VS pervasive tonic coverage) are driven principally by DAT Vmax differences, not by release-side parameters.\n  - **validates**:\n    - `hypothesis-vmax-explains-regional-difference` (panel hypothesis; epistemic hypothesis; status unknown)\n    > Regional differences in striatal DA dynamics (DS hotspots vs VS pervasive tonic coverage) are driven principally by DAT Vmax differences, not by release-side parameters.\n\n## Methodological caveats\n\n\n### Method note: `d2r-initialization-unjustified` (panel fig1H; epistemic weak; status verified)\n    > D2 receptor occupancy is initialized at 0.4 in all receptor dynamics simulations without derivation from steady state; at the modeled EC50 of 7 nM and simulated tonic [DA] of ~10 nM in DS, equilibrium occupancy would be approximately 0.59. No sensitivity analysis over this initialization is reported.\n\n  - **scopes / qualifies**:\n    - `d2r-integrates-over-seconds` (panel fig1H; epistemic weak; status verified)\n    > D2R occupancy takes at least 5 s to return to baseline after a burst due to slow off-kinetics (k_off = 0.2 s⁻¹), making D2R incapable of temporally separating closely linked bursts; the directional conclusion is robust but absolute occupancy values are sensitive to the initialization assumption.\n    - `d2r-insensitive-to-brief-pauses` (panel fig1J; epistemic weak; status verified)\n    > A complete 1 s pause in firing reduces D2R occupancy from approximately 0.55 to 0.45 only; this finding is robust across an order of magnitude of D2R affinity (2–20 nM).\n    - `d2r-occupancy-higher-in-vs` (panel fig2G; epistemic weak; status unverified:compute-infeasible)\n    > D2R occupancy during pacemaker activity is approximately 0.8 in VS versus approximately 0.55 in DS, consistent with higher prevailing tonic DA in VS.\n\n## Scope qualifiers\n\n\n### Scope: `ds-vs-vmax-ratio-assumed` (panel fig2A (implied throughout); epistemic moderate; status verified)\n    > The 3:1 DS:VS DAT Vmax ratio (DS = 6 µM·s⁻¹, VS = 2 µM·s⁻¹) is assumed from published literature rather than directly measured in this study; the immunostaining gradient (Figure 2—supplement 1) corroborates this assumption at the protein level but does not directly establish the functional Vmax ratio.\n\n  - **scopes**: ALL claims in graph\n\n### Scope: `nanoclustering-constant-vmax-constraint` (panel fig4C, fig4D, fig4E, fig4F; epistemic moderate; status verified)\n    > The nanoclustering simulations hold total DAT Vmax constant across clustered and unclustered conditions — the per-voxel rate is multiplied by a normalization factor so total integrated uptake capacity is identical; if DAT nanoclustering co-occurs with increased total DAT expression in biology, the clearance-slowing result would not hold.\n\n  - **scopes**:\n    - `dat-nanoclustering-slows-clearance` (panel fig4C, fig4D, fig4E, fig4F, fig4G; epistemic moderate; status partial:zenodo-data-downloaded)\n    > Dense DAT nanoclusters (20 nm diameter) take approximately 400 ms to clear a 100 nM DA bolus compared to approximately 200 ms for unclustered DAT, because local [DA] at the cluster surface drops near zero creating a diffusion-limited bottleneck.\n    - `hypothesis-nanoclustering-regulates-vmax` (panel hypothesis; epistemic hypothesis; status unknown)\n    > DAT nanoclustering is a possible regulator of effective transporter activity, with denser clusters lowering effective Vmax via diffusion-limited substrate access — proposed as one contributor to the regional Vmax difference.\n\n### Scope: `nanoclustering-model-varicosity-scale` (panel fig4C, fig4D, fig4E, fig4F; epistemic moderate; status verified)\n    > The nanoclustering simulations (Figure 4C–F) operate in a standalone varicosity-scale model (1.8 × 1.8 µm domain, 0.02 µm voxels) architecturally separate from the tissue-level model used in Figures 1–3 (100 µm domain, 1 µm voxels); no formal coupling exists between the two models and no effective-Vmax output from the nanoclustering simulation feeds into the tissue simulation.\n\n  - **scopes**:\n    - `dat-nanoclustering-slows-clearance` (panel fig4C, fig4D, fig4E, fig4F, fig4G; epistemic moderate; status partial:zenodo-data-downloaded)\n    > Dense DAT nanoclusters (20 nm diameter) take approximately 400 ms to clear a 100 nM DA bolus compared to approximately 200 ms for unclustered DAT, because local [DA] at the cluster surface drops near zero creating a diffusion-limited bottleneck.\n    - `hypothesis-nanoclustering-regulates-vmax` (panel hypothesis; epistemic hypothesis; status unknown)\n    > DAT nanoclustering is a possible regulator of effective transporter activity, with denser clusters lowering effective Vmax via diffusion-limited substrate access — proposed as one contributor to the regional Vmax difference.\n\n## Standalone empirical claims (not in a hypothesis loop)\n\n\n- `d2r-occupancy-higher-in-vs` (panel fig2G; epistemic weak; status unverified:compute-infeasible)\n    > D2R occupancy during pacemaker activity is approximately 0.8 in VS versus approximately 0.55 in DS, consistent with higher prevailing tonic DA in VS.\n  - requires: ['vs-maintains-pervasive-tonic-da', 'd2r-initialization-unjustified']\n\n- `low-burst-no-spillover-high-burst-does` (panel fig1G; epistemic moderate; status verified)\n    > 3 APs at 10 Hz generates no significant DA spillover outside the burst zone; 6 APs at 20 Hz and 12 APs at 40 Hz cause frequency-dependent spillover exposing 10× and 30× the burst volume to concentrations above 100 nM respectively.\n  - requires: ['ds-lacks-pervasive-tonic-da']\n\n- `vs-lowest-percentiles-above-10nm` (panel fig2D; epistemic moderate; status verified)\n    > Even the lowest DA concentration percentiles in VS exceed 10 nM during 4 Hz pacemaker activity.\n  - requires: ['vs-maintains-pervasive-tonic-da']\n\n## Dissociations\n\n\n- **d1r-tracks-da-50ms-delay ⊥ d2r-integrates-over-seconds**\n    - A: D1R occupancy closely tracks extracellular DA with approximately 50 ms delay during burst firing; D1R occupancy is negligible during pacemaker activity because the EC50 of 1000 nM far exceeds tonic [DA] of ~10 nM in DS, making burst events the effective threshold for D1R engagement.\n    - B: D2R occupancy takes at least 5 s to return to baseline after a burst due to slow off-kinetics (k_off = 0.2 s⁻¹), making D2R incapable of temporally separating closely linked bursts; the directional conclusion is robust but absolute occupancy values are sensitive to the initialization assumption.\n\n- **ds-lacks-pervasive-tonic-da ⊥ vs-maintains-pervasive-tonic-da**\n    - A: During 4 Hz pacemaker activity, the dorsal striatum produces partially segregated DA hotspots with large fractions of the simulated volume devoid of DA — there is no pervasive tonic baseline.\n    - B: With DAT Vmax reduced to 33% of DS and terminal density at 90%, VS produces a diffuse tonic-like DA level throughout the simulated volume rather than segregated hotspots during 4 Hz pacemaker activity.\n\n## Key mechanistic 'requires' dependencies\n\n- `d1r-tracks-da-50ms-delay` requires: ['ds-lacks-pervasive-tonic-da']\n- `d2r-insensitive-to-brief-pauses` requires: ['d2r-integrates-over-seconds', 'd2r-initialization-unjustified']\n- `d2r-integrates-over-seconds` requires: ['ds-lacks-pervasive-tonic-da', 'd2r-initialization-unjustified']\n- `d2r-occupancy-higher-in-vs` requires: ['vs-maintains-pervasive-tonic-da', 'd2r-initialization-unjustified']\n- `dat-nanoclustering-slows-clearance` requires: ['nanoclustering-model-varicosity-scale', 'nanoclustering-constant-vmax-constraint']\n- `ds-lacks-pervasive-tonic-da` requires: ['ds-vs-vmax-ratio-assumed']\n- `fscv-matches-may-wightman-1989` requires: ['vs-maintains-pervasive-tonic-da', 'ds-vs-vmax-ratio-assumed']\n- `low-burst-no-spillover-high-burst-does` requires: ['ds-lacks-pervasive-tonic-da']\n- `vmax-modulation-larger-impact-in-vs` requires: ['vmax-only-parameter-driving-regional-difference', 'ds-vs-vmax-ratio-assumed']\n- `vmax-only-parameter-driving-regional-difference` requires: ['vs-maintains-pervasive-tonic-da']\n- `vs-low-active-fraction-resembles-ds-distribution` requires: ['vs-maintains-pervasive-tonic-da']\n- `vs-lowest-percentiles-above-10nm` requires: ['vs-maintains-pervasive-tonic-da']\n- `vs-maintains-pervasive-tonic-da` requires: ['ds-lacks-pervasive-tonic-da', 'ds-vs-vmax-ratio-assumed']\n",
  "synthesis": "Using a tissue-scale stochastic simulation of striatal dopamine, this work argues that the contrast between dorsal and ventral striatal dopamine dynamics arises principally from differences in dopamine transporter (DAT) Vmax rather than from release-side parameters, and that this single uptake difference is sufficient to explain a cascade of downstream consequences for receptor signaling. The central argument proceeds by dissociation: at 4 Hz pacemaker firing, the dorsal striatum produces segregated DA hotspots with large unoccupied volumes, while the ventral striatum — modeled with DAT Vmax reduced to one third of DS — produces a pervasive tonic field throughout the same volume. A parameter sweep over active terminal fraction, quantal size, release probability, and firing rate establishes that only Vmax generates differential DS/VS responses, ruling out each release-side alternative in turn; this elimination is corroborated by an immunohistochemistry control showing a DAT dorsoventral gradient with no matched VMAT2 gradient, which both validates the assumed 3:1 Vmax ratio and disconfirms the differential-release explanation. Modeling FSCV responses and replicating May & Wightman (1989) provides predictive cross-validation. A second dissociation argues that D1 and D2 receptors operate on distinct temporal scales: D1R occupancy tracks burst DA with ~50 ms delay and is silent during pacemaker firing because tonic [DA] sits well below its EC50, whereas D2R integrates over seconds and cannot resolve a complete 1 s firing pause — though the authors flag that the D2R initialization is set without steady-state derivation, scoping the absolute occupancy claims (the directional conclusion is reported as robust). A third hypothesis proposes DAT nanoclustering as a candidate regulator of effective Vmax, supported by varicosity-scale simulations showing diffusion-limited clearance and dSTORM evidence of greater DAT clustering in VS; however, this strand is bounded by two explicit scope conditions — total Vmax is held constant in the cluster simulations, and the cluster model is architecturally uncoupled from the tissue model — and the empirical clustering test is flagged as failed:mismatch, leaving the link between molecular architecture and tissue-scale Vmax as a structurally proposed but not demonstrated bridge. The whole argument is qualified by the literature-derived assumption of the 3:1 DS:VS Vmax ratio.",
  "traceback": [
    {
      "move": "Central hypothesis: DAT Vmax explains DS/VS regional difference",
      "hypothesis": "hypothesis-vmax-explains-regional-difference",
      "evidence": [
        {
          "claim": "ds-lacks-pervasive-tonic-da",
          "edge": "tests/supports"
        },
        {
          "claim": "vs-maintains-pervasive-tonic-da",
          "edge": "tests/supports"
        },
        {
          "claim": "vmax-only-parameter-driving-regional-difference",
          "edge": "tests/supports + rules-out (4 release-side alternatives)"
        },
        {
          "claim": "vmax-modulation-larger-impact-in-vs",
          "edge": "tests/supports"
        },
        {
          "claim": "vs-low-active-fraction-resembles-ds-distribution",
          "edge": "tests/supports"
        },
        {
          "claim": "fscv-matches-may-wightman-1989",
          "edge": "tests/supports + validates (May & Wightman cross-replication)"
        },
        {
          "claim": "dat-immunostaining-dorsoventral-gradient",
          "edge": "supports + validates"
        },
        {
          "claim": "vmat2-gradient-absent",
          "edge": "supports + validates + rules-out (release capacity)"
        }
      ],
      "dissociation": [
        "ds-lacks-pervasive-tonic-da",
        "vs-maintains-pervasive-tonic-da"
      ]
    },
    {
      "move": "Hypothesis: D1/D2 temporal dissociation",
      "hypothesis": "hypothesis-d1-d2-temporal-distinction",
      "evidence": [
        {
          "claim": "d1r-tracks-da-50ms-delay",
          "edge": "tests/supports"
        },
        {
          "claim": "d2r-integrates-over-seconds",
          "edge": "tests/supports"
        },
        {
          "claim": "d2r-insensitive-to-brief-pauses",
          "edge": "tests/supports"
        }
      ],
      "dissociation": [
        "d1r-tracks-da-50ms-delay",
        "d2r-integrates-over-seconds"
      ],
      "scoped-by": [
        "d2r-initialization-unjustified (methodological caveat scopes the three D2R claims)"
      ]
    },
    {
      "move": "Hypothesis: nanoclustering regulates effective Vmax (proposed bridge)",
      "hypothesis": "hypothesis-nanoclustering-regulates-vmax",
      "evidence": [
        {
          "claim": "dat-nanoclustering-slows-clearance",
          "edge": "tests/supports (status partial)"
        },
        {
          "claim": "dat-clustering-greater-in-vs",
          "edge": "tests/supports (status: failed:mismatch)"
        }
      ],
      "scoped-by": [
        "nanoclustering-constant-vmax-constraint (assumption: total Vmax held constant)",
        "nanoclustering-model-varicosity-scale (architectural disconnect from tissue model)"
      ]
    },
    {
      "move": "Argument by elimination — release-side alternatives",
      "claim": "vmax-only-parameter-driving-regional-difference",
      "rules-out": [
        "differential active terminal fraction",
        "differential quantal release size",
        "differential release probability",
        "differential pacemaker firing rate"
      ]
    },
    {
      "move": "Argument by elimination — vesicular release capacity",
      "claim": "vmat2-gradient-absent",
      "rules-out": [
        "differential VMAT2 expression / vesicular release capacity"
      ]
    },
    {
      "move": "Global scope qualifier",
      "scope-claim": "ds-vs-vmax-ratio-assumed",
      "applies-to": "*",
      "note": "3:1 DS:VS DAT Vmax ratio is taken from prior literature; immunostaining only corroborates at protein level."
    },
    {
      "move": "Standalone empirical observations (not in a hypothesis loop)",
      "claims": [
        "d2r-occupancy-higher-in-vs",
        "low-burst-no-spillover-high-burst-does",
        "vs-lowest-percentiles-above-10nm"
      ]
    },
    {
      "move": "Methodological caveat",
      "claim": "d2r-initialization-unjustified",
      "scopes": [
        "d2r-integrates-over-seconds",
        "d2r-insensitive-to-brief-pauses",
        "d2r-occupancy-higher-in-vs"
      ]
    }
  ]
}